An observational study in Liver and Intrahepatic Bile Duct Neoplasm, sponsored by M.D. Anderson Cancer Center. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-12.
Sponsored by M.D. Anderson Cancer Center · Observational
This study investigates the effect of materials used in subcuticular suture on patients' outcomes after surgery. The prevention of surgical site wound infection is important to decrease the length of hospital stay and the post-operative risk of incisional hernia, especially in patients undergoing open hepatectomy (surgical removal of the liver). The purpose of this study is to compare the impact of the use of Quill versus Monocryl for subcuticular suture on patients' outcomes after surgery.
PRIMARY OBJECTIVE:
I. To investigate the impact of materials for subcuticular suture (Quill versus [vs.] Monocryl) on complications after liver resection.
OUTLINE:
Patients' medical records are reviewed retrospectively.
217 studies on the registry are indexed under Bile Duct Neoplasms; 43 are open to participants now.
This study's planned enrollment of 40 is below the median of 169 across 40 observational studies indexed under Bile Duct Neoplasms.
Browse Bile Duct Neoplasms studies →M.D. Anderson Cancer Center is the lead sponsor of 2,999 studies on the registry; 581 are open to participants now.
Of its 599 completed or terminated interventional studies of FDA-regulated products, 402 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients undergoing liver resection at MD Anderson Cancer Center from June 1, 2020 through January 31, 2021
Exclusion Criteria:
Patients' medical records are reviewed retrospectively.
Other: Electronic Health Record Review
Medical records are reviewed
Incidence of complications after liver resection
The impact of materials for subcuticular suture (Quill versus Monocryl) on complications after liver resection will be evaluated.
Time frame: 1 year
This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
M.D. Anderson Cancer Center